Advertisement

Supportive Care in Cancer

, Volume 25, Issue 12, pp 3607–3643 | Cite as

Risk factors of pain in breast cancer survivors: a systematic review and meta-analysis

  • Laurence Leysen
  • David Beckwée
  • Jo Nijs
  • Roselien Pas
  • Thomas Bilterys
  • Sofie Vermeir
  • Nele Adriaenssens
Review Article

Abstract

Background

Breast cancer remains the number 1 lethal malignancy in women. With rising incidence and decreased mortality, the number of breast cancer survivors has increased. Consequently, sequelae, such as pain, are becoming more important.

Purpose

The purpose of this study was to identify risk factors for the development of pain in breast cancer survivors.

Methods

PubMed and Web of Science were systematically screened for studies encompassing risk factors for the development of pain in breast cancer survivors. Meta-analyses were carried out for risk factors described in more than one article. Moderator analysis was performed in case of high heterogeneity (I 2 > 50%) across studies.

Results

Seventeen studies were found eligible. Meta-analyses were performed for 17 factors. Significant differences for the odds of developing chronic pain were found for BMI (overall OR: 1.34, 95%CI 1.08–1.67, p = 0.008), education (overall OR: 1.23, 95%CI 1.07–1.42, p = 0.005), lymphedema (overall OR: 2.58, 95%CI 1.93–3.46, p < 0.00001), smoking status (overall OR: 0.75, 95%CI 0.62–0.92, p = 0.005), axillary lymph node dissection (overall OR: 1.25, 95%CI 1.04–1.52, p = 0.02), chemotherapy (overall OR: 1.44, 95%CI 1.24–1.68, p < 0.00001), and radiotherapy (overall OR: 1.32, 95%CI 1.17–1.48, p < 0.00001). After performing moderator analyses for age, comorbidities, hormone therapy, and breast surgery, hormone therapy became a significant risk factor as well (overall OR: 1.33, 95%CI 1.15–1.54, p = 0.0001).

Conclusion

BMI > 30, education < 12–13 years, lymphedema, not smoking, axillary lymph node dissection, chemotherapy, hormone therapy, and radiotherapy were significantly associated with higher odds for the development of chronic pain, with lymphedema being the biggest risk factor. Lack of uniformity across the studies in defining pain, follow-up, measurement tools, and cut-off values for the diagnosis of pain was noted, resulting in greater inter-study variability.

Keywords

Chronic pain Pain Breast cancer survivor Risk factors 

Notes

Compliance with ethical standards

Funding

Jo Nijs is holder of a Chair funded by the Berekuyl Academy, the Netherlands. Roselien Pas is a PhD student funded by the Berekuyl Acadely Chair.

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

520_2017_3824_MOESM1_ESM.pdf (522 kb)
ESM 1 (PDF 522 kb)

References

  1. 1.
    Ferlay J et al (2015) Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386CrossRefPubMedGoogle Scholar
  2. 2.
    Ferlay J et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917CrossRefPubMedGoogle Scholar
  3. 3.
    Katanoda K, Matsuda T (2014) Five-year relative survival rate of breast cancer in the USA, Europe and Japan. Jpn J Clin Oncol 44(6):611CrossRefPubMedGoogle Scholar
  4. 4.
    Organization, W.H., World cancer report 2014. 2014, Lyonn, France: International Agency for Research on Cancer.Google Scholar
  5. 5.
    Befort CA, Klemp J (2011) Sequelae of breast cancer and the influence of menopausal status at diagnosis among rural breast cancer survivors. J Women's Health 20(9):1307–1313CrossRefGoogle Scholar
  6. 6.
    Glare PA et al (2014) Pain in cancer survivors. J Clin Oncol 32(16):1739–1747CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Forsythe LP et al (2013) Pain in long-term breast cancer survivors: The role of body mass index, physical activity, and sedentary behavior. Breast Cancer Res Treat 137(2):617–630CrossRefPubMedGoogle Scholar
  8. 8.
    Pain, I.A.f.t.S.o. Pain, IASP Taxonomy. 2014 2014–10-06 [cited 2016 2016–03-26]; Available from: http://www.iasp-pain.org/Taxonomy - Pain.
  9. 9.
    Merskey, H. and N. Bogduk, Eds. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Second edition ed. 1994, IASP Press: SeattleGoogle Scholar
  10. 10.
    Chang SH, Metha V, Langford R (2009) Acute and chronic pain following breast surgery. Acute Pain 11(1):1–14CrossRefGoogle Scholar
  11. 11.
    Andersen KG, Kehlet H (2011) Persistent pain after breast cancer treatment: A critical review of risk factors and strategies for prevention. J Pain 12(7):725–746CrossRefPubMedGoogle Scholar
  12. 12.
    Liberati A et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J Clin Epidemiol 62(10):e1–34CrossRefPubMedGoogle Scholar
  13. 13.
    NCI, O.o.C.S., About Cancer Survivorship Research: Survivorship Definitions.. 2012, Washington, DCGoogle Scholar
  14. 14.
    Elmagarmid, A., et al., Rayyan: a systematic reviews web app for exploring and filtering searches for eligible studies for Cochrane Reviews., in Evidence-Informed Public Health: Opportunities and Challenges. Abstracts of the 22nd Cochrane Colloquium. 2014, John Wiley & sons: Hyderabad, IndiaGoogle Scholar
  15. 15.
    Bredal IS et al (2014) Chronic pain in breast cancer survivors: Comparison of psychosocial, surgical, and medical characteristics between survivors with and without pain. J Pain Symptom Manag 48(5):852–862CrossRefGoogle Scholar
  16. 16.
    Moloney N et al (2016) Prevalence and risk factors associated with pain 21 months following surgery for breast cancer. Support Care Cancer 24(11):4533–4539CrossRefPubMedGoogle Scholar
  17. 17.
    Steyaert A et al (2016) Does the perioperative analgesic/anesthetic regimen influence the prevalence of long-term chronic pain after mastectomy? J Clin Anesth 33:20–25CrossRefPubMedGoogle Scholar
  18. 18.
    von Elm E et al (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg (London, England) 12(12):1495–1499CrossRefGoogle Scholar
  19. 19.
    Higgins JP et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Higgins, J.P.T. and S. Green, Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 [updated September 2008]. Chapter 9: Analysing data and undertaking meta-analyses., ed. J.J. Deeks, J.P.T. Higgins, and D.G. Altman. 2008: The Cochrane Collaboration.Google Scholar
  21. 21.
    Johannsen M et al (2015) Socio-demographic, treatment-related, and health behavioral predictors of persistent pain 15 months and 7-9 years after surgery: A nationwide prospective study of women treated for primary breast cancer. Breast Cancer Res Treat 152(3):645–658CrossRefPubMedGoogle Scholar
  22. 22.
    Peuckmann V et al (2009) Chronic pain and other sequelae in long-term breast cancer survivors: Nationwide survey in Denmark. Eur J Pain 13(5):478–485CrossRefPubMedGoogle Scholar
  23. 23.
    Romero A et al (2016) Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs. BMC Cancer 16Google Scholar
  24. 24.
    Andersen Juhl A, Christiansen P, Damsgaard TE (2016) Persistent pain after breast cancer treatment: A questionnaire-based study on the prevalence, associated treatment variables, and pain type. J Breast Cancer 19(4):447–454Google Scholar
  25. 25.
    Alkan A et al (2016) Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): A study of the palliative care working committee of the Turkish oncology group (TOG). Support Care Cancer 24(9):3747–3755CrossRefPubMedGoogle Scholar
  26. 26.
    Lundstedt D et al (2015) Radiation therapy to the plexus brachialis in breast cancer patients: Analysis of paresthesia in relation to dose and volume. Int J Radiat Oncol Biol Phys 92(2):277–283CrossRefPubMedGoogle Scholar
  27. 27.
    Bantema-Joppe EJ et al (2012) Simultaneous integrated boost irradiation after breast-conserving surgery: Physician-rated toxicity and cosmetic outcome at 30 months' follow-up. Int J Radiat Oncol Biol Phys 83(4):e471–e477CrossRefPubMedGoogle Scholar
  28. 28.
    Bell RJ et al (2014) Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment. J Cancer Surviv 8(1):1–8CrossRefPubMedGoogle Scholar
  29. 29.
    Gulluoglu BM et al (2006) Factors related to post-treatment chronic pain in breast cancer survivors: The interference of pain with life functions. Int J Fertil Womens Med 51(2):75–82PubMedGoogle Scholar
  30. 30.
    Calhoun C, Helzlsouer KJ, Gallicchio L (2015) Racial differences in depressive symptoms and self-rated health among breast cancer survivors on aromatase inhibitor therapy. J Psychosoc Oncol 33(3):263–277CrossRefPubMedGoogle Scholar
  31. 31.
    Crandall C et al (2004) Association of breast cancer and its therapy with menopause-related symptoms. Menopause- J North Am Menopause Soc 11(5):519–530CrossRefGoogle Scholar
  32. 32.
    van Londen GJ et al (2014) Associations between adjuvant endocrine therapy and onset of physical and emotional concerns among breast cancer survivors. Support Care Cancer 22(4):937–945CrossRefPubMedGoogle Scholar
  33. 33.
    Lundstedt D et al (2010) Symptoms 10-17 years after breast cancer radiotherapy data from the randomised SWEBCG91-RT trial. Radiother Oncol 97(2):281–287CrossRefPubMedGoogle Scholar
  34. 34.
    Crandall C et al (2004) Association of breast cancer and its therapy with menopause-related symptoms. Menopause 11(5):519–530CrossRefPubMedGoogle Scholar
  35. 35.
    Bell RJ et al (2014) Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment. Journal of Cancer Survivorship 8(1):1–8Google Scholar
  36. 36.
    Berrios-Rivera R, Rivero-Vergine A, Romero I (2008) The pediatric cancer hospitalization experience: Reality co-constructed. J Pediatr Oncol Nurs 25(6):340–353CrossRefPubMedGoogle Scholar
  37. 37.
    Kim SJ, Park YD (2008) Effects of complex decongestive physiotherapy on the oedema and the quality of life of lower unilateral lymphoedema following treatment for gynecological cancer. Eur J Cancer Care (Engl) 17(5):463–468CrossRefGoogle Scholar
  38. 38.
    Jeong HJ et al (2011) Causes of shoulder pain in women with breast cancer-related lymphedema: A pilot study. Yonsei Med J 52(4):661–667CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Taylor RJ et al (2014) Pain and obesity in the older adult. Curr Pharm Des 20(38):6037–6041CrossRefPubMedGoogle Scholar
  40. 40.
    Okifuji A, Hare BD (2015) The association between chronic pain and obesity. J Pain Res 14(8):399–408CrossRefGoogle Scholar
  41. 41.
    Piper, M., et al (2016), Axillary Web Syndrome: Current Understanding and New Directions for Treatment. Ann Plast SurgGoogle Scholar
  42. 42.
    Yeung WM, McPhail SM, Kuys SS (2015) A systematic review of axillary web syndrome (AWS). J Cancer Surviv 9(4):576–598CrossRefPubMedGoogle Scholar
  43. 43.
    Cregg R, Anwar S, Farquhar-Smith P (2013) Persistent postsurgical pain. Curr Opin Support Palliat Care 7(2):144–152CrossRefPubMedGoogle Scholar
  44. 44.
    Shipton EA (2011) The transition from acute to chronic post surgical pain. Anaesth Intensive Care 39(5):824–836PubMedGoogle Scholar
  45. 45.
    Delanian S, Lefaix JL, Pradat PF (2012) Radiation-induced neuropathy in cancer survivors. Radiother Oncol 105(3):273–282CrossRefPubMedGoogle Scholar
  46. 46.
    Grisold W, Cavaletti G, Windebank AJ (2012) Peripheral neuropathies from chemotherapeutics and targeted agents: Diagnosis, treatment, and prevention. Neuro-Oncology 14:45–54CrossRefGoogle Scholar
  47. 47.
    Bhagra A, Rao RD (2007) Chemotherapy-induced neuropathy. Curr Oncol Rep 9(4):290–299CrossRefPubMedGoogle Scholar
  48. 48.
    Boland EG et al (2014) Central pain processing in chronic chemotherapy-induced peripheral neuropathy: A functional magnetic resonance imaging study. PLoS One 9(5):e96474CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Lee E et al (2016) Characterization of risk factors for adjuvant radiotherapy-associated pain in a tri-racial/ethnic breast cancer population. Pain 157(5):1122–1131CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Burton AW et al (2007) Chronic pain in the cancer survivor: A new frontier. Pain Med 8(2):189–198CrossRefPubMedGoogle Scholar
  51. 51.
    Levy MH, Chwistek M, Mehta RS (2008) Management of chronic pain in cancer survivors. Cancer J 14(6):401–9Google Scholar
  52. 52.
    Altundag K, Ibrahim NK (2006) Aromatase inhibitors in breast cancer: An overview. Oncologist 11(6):553–562CrossRefPubMedGoogle Scholar
  53. 53.
    Mao JJ et al (2009) Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer 115(16):3631–3639CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Beckwee, D., et al. (2017) Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: A systematic review and meta-analysis. Support Care CancerGoogle Scholar
  55. 55.
    Howell A et al (2005) Results of the ATAC (Arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365(9453):60–62CrossRefPubMedGoogle Scholar
  56. 56.
    Goss PE et al (2003) A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349(19):1793–1802CrossRefPubMedGoogle Scholar
  57. 57.
    Jakesz R et al (2005) Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: Combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366(9484):455–462CrossRefPubMedGoogle Scholar
  58. 58.
    Burstein HJ (2007) Aromatase inhibitor-associated arthralgia syndrome. Breast 16(3):223–234CrossRefPubMedGoogle Scholar
  59. 59.
    Peppone LJ et al (2015) The effect of YOCAS(c)((R)) yoga for musculoskeletal symptoms among breast cancer survivors on hormonal therapy. Breast Cancer Res Treat 150(3):597–604CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Hershman DL, Loprinzi C, Schneider BP (2015) Symptoms: Aromatase inhibitor induced Arthralgias. Adv Exp Med Biol 862:89–100CrossRefPubMedGoogle Scholar
  61. 61.
    Fusi C et al (2014) Steroidal and non-steroidal third-generation aromatase inhibitors induce pain-like symptoms via TRPA1. Nat Commun 5:5736CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Turk DC, Wilson HD (2010) Fear of pain as a prognostic factor in chronic pain: Conceptual models, assessment, and treatment implications. Curr Pain Headache Rep 14(2):88–95CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Boersma K, Linton SJ (2005) Screening to identify patients at risk: Profiles of psychological risk factors for early intervention. Clin J Pain 21(1):38–43CrossRefPubMedGoogle Scholar
  64. 64.
    Rashiq S, Dick BD (2014) Post-surgical pain syndromes: A review for the non-pain specialist. Can J Anesth 61(2):123–130CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  • Laurence Leysen
    • 1
    • 2
  • David Beckwée
    • 2
    • 3
  • Jo Nijs
    • 1
    • 2
    • 4
  • Roselien Pas
    • 1
    • 2
  • Thomas Bilterys
    • 2
  • Sofie Vermeir
    • 2
  • Nele Adriaenssens
    • 2
    • 5
  1. 1.Pain in Motion International Research Group
  2. 2.Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education and PhysiotherapyVrije Universiteit BrusselBrusselsBelgium
  3. 3.Department of Rehabilitation Sciences and Physiotherapy, Faculty of Medicine and Health SciencesUniversity of AntwerpWilrijkBelgium
  4. 4.Department of OncologyUniversity Hospital BrusselsBrusselsBelgium
  5. 5.Department of Physical Medicine and PhysiotherapyUniversity Hospital BrusselsBrusselsBelgium

Personalised recommendations